Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Inside MS: Explore how BTK drives immune cell activation and CNS damage

T1D: Debunking the Age Myth

An infographic describing the prevalence of and challenges faced in diagnosing adult-onset T1D 

IMD: Why Every Hour Matters in Meningococcal Disease Management

Learn about the rapid progression of Invasive Meningococcal Disease (IMD), its clinical manifestations, and why early diagnosis is crucial for patient survival.

IMD Complications & Family Burden: Understanding the Multi-dimensional Impact

Explore the comprehensive impact of Invasive Meningococcal Disease (IMD), including family burden, survivor complications, and quality of life effects. Learn about neurological and non-neurological complications affecting IMD survivors.